ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,552.77
-1.02%
S&P 500
5,421.03
0.85%
Dow Jones
38,712.21
-0.09%
US Dollar vs Yen
157.2445
0.28%
Brent Oil
81.885
-0.50%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE
  6. Bivictrix Therapeutics Plc (BVX)

  7. Bivictrix Therapeutics Plc (BVX) ニュース

BVX

Bivictrix Therapeutics (BVX)

Bivictrix Therapeutics Plc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:BVX
日付受信時刻ニュースソース見出しコード企業名
2024/06/1315 : 00RNS Regulatory NewsBiVictriX Therapeutics PLC Compelling Safety Profile of BVX001LSE:BVXBivictrix Therapeutics Plc
2024/06/0615 : 00RNS Regulatory NewsBiVictriX Therapeutics PLC Innovate UK Grant Award to Accelerate ADC PipelineLSE:BVXBivictrix Therapeutics Plc
2024/06/0103 : 00Alliance NewsAlliance NewsEARNINGS AND TRADING: CT UK High Income tops benchmark, ups dividendLSE:BVXBivictrix Therapeutics Plc
2024/05/3116 : 44RNS Regulatory NewsBiVictriX Therapeutics PLC BiVictriX – Full Year Results 2023LSE:BVXBivictrix Therapeutics Plc
2024/04/1722 : 23Alliance NewsAlliance NewsBivictrix granted FDA orphan drug status for rare cancer treatmentLSE:BVXBivictrix Therapeutics Plc
2024/04/1715 : 00RNS Regulatory NewsBiVictriX Therapeutics PLC Orphan Drug Designation & FDA INTERACT MeetingLSE:BVXBivictrix Therapeutics Plc
2024/03/2816 : 00RNS Regulatory NewsBiVictriX Therapeutics PLC Grant of Options – PDMR/Director DealingsLSE:BVXBivictrix Therapeutics Plc
2024/01/0421 : 30UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2024/01/0421 : 30UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2024/01/0416 : 00UK RegulatoryBiVictriX Therapeutics PLC BiVictriX Hosts Inaugural Roundtable DiscussionLSE:BVXBivictrix Therapeutics Plc
2023/12/0520 : 08UK RegulatoryBiVictriX Therapeutics PLC Board ChangeLSE:BVXBivictrix Therapeutics Plc
2023/11/3021 : 08Alliance NewsAlliance NewsIN BRIEF: Bivictrix selects final sequences for lead tumour programmeLSE:BVXBivictrix Therapeutics Plc
2023/11/3016 : 00UK RegulatoryBiVictriX Therapeutics PLC Pipeline update on BVX002LSE:BVXBivictrix Therapeutics Plc
2023/11/2302 : 14UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2023/11/1522 : 05Alliance NewsAlliance NewsTRADING UPDATES: BiVictriX patent boost; 4Global deal extendedLSE:BVXBivictrix Therapeutics Plc
2023/11/1516 : 00UK RegulatoryBiVictriX Therapeutics PLC Patent Granted in JapanLSE:BVXBivictrix Therapeutics Plc
2023/10/1220 : 04Alliance NewsAlliance NewsBivictrix says BVX001 increases survival rates by more than doubleLSE:BVXBivictrix Therapeutics Plc
2023/10/1215 : 00UK RegulatoryBiVictriX Therapeutics PLC Extended Survival Rates Reported with BVX001LSE:BVXBivictrix Therapeutics Plc
2023/10/0320 : 06Alliance NewsAlliance NewsBivictrix hires new CFO as Alex Hughes steps down after seven monthsLSE:BVXBivictrix Therapeutics Plc
2023/10/0315 : 00UK RegulatoryBiVictriX Therapeutics PLC Appointment of Adrian Howd as CFO and CBOLSE:BVXBivictrix Therapeutics Plc
2023/09/2001 : 30Alliance NewsAlliance NewsTRADING UPDATES: AEW UK REIT appoints new chair; Oberon raises moneyLSE:BVXBivictrix Therapeutics Plc
2023/09/1915 : 00UK RegulatoryBiVictriX Therapeutics PLC Interim ResultsLSE:BVXBivictrix Therapeutics Plc
2023/08/3115 : 00UK RegulatoryBiVictriX Therapeutics PLC Total Voting RightsLSE:BVXBivictrix Therapeutics Plc
2023/08/2317 : 30Alliance NewsAlliance NewsBivictrix Therapeutics granted US patent for cancer drug BVX001LSE:BVXBivictrix Therapeutics Plc
2023/08/2315 : 00UK RegulatoryBiVictriX Therapeutics PLC US Patent GrantedLSE:BVXBivictrix Therapeutics Plc
2023/08/1715 : 00UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2023/08/1702 : 00UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2023/08/1200 : 17UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2023/08/0901 : 18UK RegulatoryBiVictriX Therapeutics PLC Result of General MeetingLSE:BVXBivictrix Therapeutics Plc
2023/07/2003 : 30Alliance NewsAlliance NewsUPDATE: Bivictrix Therapeutics raises GBP2.1 million through fundraiseLSE:BVXBivictrix Therapeutics Plc
 Showing the most relevant articles for your search:LSE:BVX

最近閲覧した銘柄

BIT
UC3S7Y
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有